Locations
Woburn, MA, USA
industry
Biotechnology · DeepTech · Health
Size
1 - 10 employees
Stage
Series C+
founded in
2016
Axial Therapeutics is a clinical stage biopharmaceutical company focused on developing innovative small molecule therapeutics that leverage the gut microbiome to treat neurological diseases and disorders, including autism spectrum disorder and Parkinson’s disease. Their Microbial-Inspired Therapeutics® platform aims to identify new drug targets in the gut, offering a unique approach to drug discovery that differentiates them in the market. With a robust pipeline and ongoing clinical trials, Axial is positioned to address significant unmet patient needs and improve the quality of life for individuals affected by these conditions.
Something looks off?